Interim OS showed a trend in favor of T-VEC; HR 0.79 (95% CI 0.61, 1.02) which did not reach statistical significance.
← all excerpts
Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016.
1
—
—
Interim OS showed a trend in favor of T-VEC; HR 0.79 (95% CI 0.61, 1.02) which did not reach statistical significance.